Phase
Alumni
Thyrolytics
Thyrolytics AB develops a first-of-its-kind diagnostic device for measuring thyroid hormone levels in the blood using nanotechnology and protein engineering. In contrast to the convectional diagnostic methods for thyroid disorders, Thyrolytics’ patent pending platform directly measures the thyroid hormone levels, resulting in a highly robust, reliable and costeffective point-of-care diagnostic method.
Mohamad Takwa obtained his Ph.D in biotechnology from KTHStockholm and M.Sc in Molecular Biotechnology from the University of Milano-Bicocca. He has been involved in the earlystage establishment of multiple successful biotech and life science companies. Mohamad combines his passion for science and innovation to help cutting edge biotech technologies from bench to the market.
Did you know?
In Sweden, 458’000 patients are treated for hypothyroidism and among them: 92’000 are not feeling well despite the treatment and 46’000 are on full or partial sick leave. These numbers are highest that all other chronic diseases.
Excellence in solid material analysis
Amplify the efficacy of pharmaceutical treatments
Simplify medicine information through digital services
A "check-in buddy" for the elderly
Excellence in inhaler performance
Behavioral coaching app
Antibiotic-free treatment for vaginal bacterial infections
Digital tool for meeting an allergy doctor
Cutting-Edge Histological Solutions for Pharma Industry
Digital communication tool for titrating medicine
Mobile systems for movement analysis
Innovative solutions for better health care
GPS tracker system for elderly
Drug delivery platform
Healthtech for children with eating challenges
Digital health management tool
Short chain fatty acids can be delivered to the colon
Therapeutics after stroke
Starch pickering emulsion technology
Measuring thyroid hormone levels
Gene editing analysis solution
Cost-effective & rapid COVID-19 diagnostic test
eHealth clinic for obesity treatment
